Arunee Dechaphunkul

Determination of Exploratory Metastasis Biomarkers in Cancer of Unknown Primary Using Metastatic Colon Cancer as a Model: RNA Sequencing Bioinformatics Analysis

We aimed to explore the real-world practice setting and identify common genetic signaling or patterns in cancer of unknown primary (CUP) using colon cancer as a model through RNA sequencing bioinformatics analysis. Data were retrieved and analyzed using the hospital information s...

Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study

Patients with esophageal squamous cell carcinoma (ESCC) have an unmet need for new therapies that improve survival. In this phase II trial, patients received ociperlimab and tislelizumab (A) or placebo and tislelizumab (B) (NCT04732494). The primary endpoint was objective respons...

Landscape of industry-sponsored oncology trials across the Thai Society of Clinical Oncology (TSCO): a 12-year multicenter analysis

Cancer remains a major global health challenge and is a leading cause of morbidity and mortality in Thailand. Industry-sponsored oncology trials (ISOTs) provide critical access to innovative therapies, including targeted agents, immunotherapies (IO), and antibody–drug conjugates...